{"schemaVersion":1,"research":true,"symbol":"clx","name":"Clorox Co","topic":"moat","path":"/stock/clx/moat","status":"published","version":10,"updatedAt":"2026-10-19T10:18:25.029Z","locked":false,"publicFairValue":false,"fairValue":null,"moat":{"verdict":"narrow","summary":"Clorox has a limited intangible-asset moat supported by reported fiscal 2025 market-share gains, established brands and Glad’s retained exclusive, royalty-free core intellectual property licenses. Pricing actions supported fiscal 2024 margin recovery, but subsequent promotional pressure, weak price/mix outcomes and fiscal 2026 margin erosion limit demonstrated pricing power. ERP-related shipment timing explains much of the sales decline; separately, management acknowledged competitive pressure and missed expectations. Neither broad customer dependency nor exceptional durability is established.","advantages":[{"mechanism":"intangible_assets","claim":"Brand recognition and Glad’s exclusive core intellectual property licenses provide a limited basis for differentiation. Reported fiscal 2025 market-share gains support the commercial relevance of the portfolio; the licenses are an existing contractual advantage after the venture’s termination.","durability":"The retained licenses support continuity beyond the venture, but the passages do not establish their remaining protection period or economic contribution. Brand relevance requires continuing advertising and innovation, making durability conditional.","risks":"Private-label and alternative products compete on price and performance. Fiscal 2026 brought acknowledged competitive pressure and missed expectations. Ongoing promotional support and concentrated retail customers constrain monetization. ERP efficiencies and acquisition synergies remain potential benefits.","invalidation":"The thesis would fail if sustained market-share losses and worsening net price realization persisted after ERP inventory effects normalized, or if Glad’s licensed technology lost exclusivity, enforceability or meaningful product differentiation.","competitors":[],"evidenceIds":["e1","e2","e3","e4"],"counterEvidenceIds":["e5","e6","e7","e8","e9","e10","e11"]}],"evidence":[{"id":"e1","sourceId":"filing-2","location":"Fiscal 2025 business overview: reported market-share growth","excerpt":"While net sales were \n1\nTable of Contents \nessentially flat in fiscal year 2025, the Company grew overall market share while also expanding gross margin."},{"id":"e2","sourceId":"filing-1","location":"Note 9: retained Glad intellectual property licenses","excerpt":"The Glad business will continue to retain the exclusive core intellectual property licenses contributed by P&G on a royalty-free basis for the licensed products marketed."},{"id":"e3","sourceId":"filing-3","location":"Competition: product performance, brand recognition and price","excerpt":"The Company’s products generally compete on the basis of product performance, brand reputation and recognition, image and price."},{"id":"e4","sourceId":"filing-1","location":"Segment disclosures: marketed brand portfolio","excerpt":"Products within this segment include laundry additives and home care products primarily marketed under the Clorox, Poett, Pine-Sol, Clorinda and Chux brands; bags and wraps under the Glad brand; cat litter primarily marketed under the Ever Clean and Fresh Step brands and water-filtration products marketed under the Brita brand."},{"id":"e5","sourceId":"filing-3","location":"Competition: nationally advertised and private-label brands","excerpt":"The Company’s products compete with other nationally advertised brands and with “private label” brands within each category."},{"id":"e6","sourceId":"filing-3","location":"Competition: continuing advertising and innovation requirements","excerpt":"If a product gains consumer acceptance, it typically requires continued advertising and promotional support and ongoing product innovation to maintain its relative market position."},{"id":"e7","sourceId":"filing-6","location":"Compensation discussion: ERP challenges and weaker second-half performance","excerpt":"ERP transition, the significant year-over-year impact of the related inventory drawdown, and lower-than-anticipated business performance in the second half amid slower category growth and increased competitive activity."},{"id":"e8","sourceId":"filing-6","location":"Compensation discussion: missed internal goals and public expectations","excerpt":"Although we improved our performance on relevant measures in the second half of the year, we did not meet the goals we set for ourselves or the expectations we provided publicly."},{"id":"e9","sourceId":"filing-1","location":"Fiscal 2026 results: segment sales, volume and price/mix/other bridge","excerpt":"Reported (GAAP) Net Sales Growth / (Decrease)\nReported Volume\nAcquisitions & Divestitures (1)\nForeign Exchange Impact\nPrice/Mix/ Other (2)\nOrganic Sales Growth / (Decrease) (Non-GAAP) (3)\nOrganic Volume (4)\nHealth and Wellness (4)\n— \n%\n(1)\n%\n8 \n%\n— \n%\n1 \n%\n(8)\n%\n(8)\n%\nHousehold\n(11)\n(9)\n— \n— \n(2)\n(11)\n(9)\nLifestyle\n(14)\n(12)\n— \n— \n(2)\n(14)\n(12)\nInternational\n5 \n— \n— \n3 \n2 \n2 \n— \nTotal Company (4)(5) \n(5)\n%\n(5)\n%\n3 \n%\n— \n%\n— \n%\n(8)\n%\n(7)\n%\n(1)The divestiture impact is calculated as net sales from the Better Health VMS business after the sale date in the twelve month year-ago period."},{"id":"e10","sourceId":"filing-1","location":"Fiscal 2026 results: gross-margin contraction","excerpt":"% Change\n2026\n2025\n2026 to\n2025\nGross profit\n$\n2,844\n$\n3,213\n(11)\n%\nGross margin\n42.3 \n%\n45.2 \n%\nGross margin decreased by 290 basis points in fiscal year 2026 from 45.2% to 42.3%."},{"id":"e11","sourceId":"filing-1","location":"Note 22: largest-customer sales concentration","excerpt":"and its affiliates, were 26%, 27% and 25% of consolidated net sales for each of the fiscal years ended June 30, 2026, 2025 and 2024, respectively, and occurred across all of the \n68\nNOTE 22."},{"id":"e12","sourceId":"filing-3","location":"Fiscal 2024 business overview: realized pricing and cost-saving benefits","excerpt":"While net sales decreased mainly due to the disruptions caused by the cyberattack, the Company rebuilt gross margin primarily due to the benefit of pricing actions and continued positive returns from its trademark cost savings program."},{"id":"e13","sourceId":"filing-2","location":"Fiscal 2025 business overview: unfavorable mix and higher trade promotion spending","excerpt":"Diluted net earnings per share (EPS) increased 190% compared to the year-ago period, primarily due to the losses on the divestiture of the Argentina business in the prior period, higher volume in the current period, the pension settlement charge in the prior period and cost savings and the benefits of cyberattack insurance recoveries in the current period, partially offset by the loss relating to the divestiture of the Better Health Vitamins, Minerals and Supplements (VMS) business, unfavorable mix and higher trade promotion spending all in the current period."},{"id":"e14","sourceId":"filing-1","location":"Fiscal 2026 sales bridge: definition of price/mix/other","excerpt":"(2)This represents the net impact on net sales growth / (decrease) from pricing actions, mix, trade promotion spending, mix from acquisitions and divestitures and other factors."},{"id":"e15","sourceId":"filing-1","location":"Fiscal 2026 results: shipment timing and acquisition effects","excerpt":"Net sales and volume both decreased by 5% in fiscal year 2026, primarily due to lower shipments in the current period following the incremental shipments related to the ERP transition in the fourth quarter of fiscal year 2025, partially offset by the benefit of the GOJO acquisition."},{"id":"e16","sourceId":"filing-1","location":"Fiscal 2026 results: causes of gross-margin contraction","excerpt":"The decrease was primarily driven by lower net sales and higher manufacturing and logistics costs, partially offset by cost savings."},{"id":"e17","sourceId":"filing-1","location":"Revenue accounting: customer performance-obligation duration","excerpt":"All performance obligations under the terms of contracts with customers have an original duration of one year or less."},{"id":"e18","sourceId":"filing-1","location":"Revenue accounting: price reductions and promotional programs","excerpt":"The Company has trade promotion programs, which primarily include shelf price reductions, in-store merchandising and consumer coupons."},{"id":"e19","sourceId":"filing-1","location":"Liquidity: operating cash flow, capital expenditure and adjusted free cash flow reconciliation","excerpt":"Adjusted free cash flow\n2026\n2025\nNet cash provided by operations\n$\n612 \n$\n981 \nLess: Capital expenditures\n(207)\n(220)\nAdd: Venture agreement termination payment\n476 \n— \nAdjusted free cash flow\n$\n881 \n$\n761 \nAdjusted free cash flow as a percentage of net sales\n13.1 \n%\n10.7 \n%\nFinancing Activities\nNet cash provided by financing activities was $1,668 in fiscal year 2026, compared with net cash used of $924 in fiscal year 2025."},{"id":"e20","sourceId":"filing-1","location":"Financing: fiscal 2026 completed share repurchases","excerpt":"During the fiscal year ended June 30, 2026, the Company repurchased 2,157 thousand shares of common stock at a cost of $254."},{"id":"e21","sourceId":"filing-1","location":"Financing: dividends paid and subsequent dividend declaration","excerpt":"Dividends per share and total dividends paid to Clorox stockholders were as follows during the fiscal years ended June 30:\n2026\n2025\nDividends per share declared\n$\n4.96 \n$\n4.88 \nDividends per share paid\n4.96 \n4.88 \nTotal dividends paid\n602 \n602 \nOn July 31, 2026, the Company declared a 1% increase in the quarterly dividend, from $1.24 to $1.25 per share, payable on August 28, 2026 to common stockholders of record as of the close of business on August 12, 2026."},{"id":"e22","sourceId":"filing-1","location":"Cautionary statement: increased acquisition-related debt and actual credit downgrade","excerpt":"•the effect of the Company’s indebtedness and credit ratings, including increased indebtedness resulting from the GOJO acquisition and Glad joint venture buyout and the recent downgrade of the Company's long-term credit rating by S&P Global Ratings, on its business operations and financial results and the Company’s ability to access capital markets and other funding sources, as well as the cost of capital to the Company;"},{"id":"e23","sourceId":"filing-1","location":"Strategic initiatives: completed transformation investment","excerpt":"The total incremental transformational investment was approximately $580 million."},{"id":"e24","sourceId":"filing-1","location":"Strategic initiatives: fiscal 2026 implementation completion","excerpt":"operations in fiscal year 2026. The Company completed its implementation in the third quarter of fiscal year 2026."},{"id":"e25","sourceId":"filing-2","location":"Fiscal 2025 overview: expected transformation investment range","excerpt":"in fiscal year 2026. The total incremental transformational investment is expected to be $570 to $580 million."},{"id":"e26","sourceId":"filing-6","location":"Compensation discussion: actual fiscal 2026 short-term incentive multiplier","excerpt":"The Company multiplier for our short-term incentive for fiscal year 2026 was 54%.The result reflected operational challenges early in the year associated with our U.S."},{"id":"e27","sourceId":"filing-6","location":"Compensation discussion: certified July 2026 performance-share payout","excerpt":"for the second and third years. In July 2026, the MDCC certified a final payout for the 2023 PSUs at 69% of target."},{"id":"e28","sourceId":"filing-6","location":"Compensation discussion: executive net-share retention requirement","excerpt":"of net shares acquired after tax withholding until the minimum ownership level is met."},{"id":"e29","sourceId":"filing-6","location":"Board leadership: combined chair and CEO with lead independent director","excerpt":"Board leadership structure is comprised of a combined Board chair and CEO, a strong lead independent director, and"},{"id":"e30","sourceId":"filing-6","location":"Board leadership: independent committee chairs","excerpt":"independent Board committee chairs."},{"id":"e31","sourceId":"filing-6","location":"Lead independent director letter: independent CEO search committee","excerpt":"Following Linda Rendle’s decision to step down as CEO, the Board established an independent CEO Search Committee, which"},{"id":"e32","sourceId":"filing-1","location":"Independent auditor opinion: effective internal control over financial reporting","excerpt":"In our opinion, The Clorox Company (the Company) maintained, in all material respects, effective internal control over financial reporting as of June 30, 2026, based on the COSO criteria."},{"id":"e33","sourceId":"filing-1","location":"Internal-control audit: acquired GOJO business excluded from management assessment","excerpt":"As indicated in the accompanying management’s report on internal control over financial reporting, management’s assessment of and conclusion on the effectiveness of internal control over financial reporting did not include the internal controls of GOJO Industries, Inc., which is included in the 2026 consolidated financial statements of the Company and constituted 30% of total assets as of June 30, 2026 and 3% and 1% of net sales and net earnings attributable to Clorox, respectively, for the year then ended."},{"id":"e34","sourceId":"filing-1","location":"Internal-control audit: acquired GOJO business excluded from auditor evaluation","excerpt":"Our audit of internal control over financial reporting of the Company also did not include an evaluation of the internal control over financial reporting of GOJO Industries, Inc."},{"id":"e35","sourceId":"filing-1","location":"Strategic initiatives: prospective transformation efficiencies","excerpt":"It is expected that these implementations will generate efficiencies and transform the Company's operations in the areas of supply chain, digital commerce, innovation, brand building and more over the long term."},{"id":"e36","sourceId":"filing-1","location":"Acquisition accounting: expected GOJO synergies","excerpt":"The goodwill represents expected synergies from complementary expertise and business-to-business capabilities as well as both near-term and long-term strategic value to the Company."}],"changes":["Retains the previous narrow verdict, with the moat explicitly limited to brand differentiation and retained Glad intellectual property.","Adds criterion-level pricing and management assessments, including actual incentive payouts and governance disclosures.","Separates demonstrated competitive pressure and missed expectations from generic risk factors, and avoids attributing ERP-related shipment declines entirely to lost consumer demand."],"limitations":["Assessment uses only supplied passages. Source dates are filing dates: August 8, 2024; August 8, 2025; February 3, April 30, August 7 and October 7, 2026.","Competitor coverage identifies generic categories rather than named rivals. P&G is disclosed as a venture partner and licensor; other named companies appear as customers, advisers or biographical references and are not established as competitors.","Reported market-share gains and explanations of pricing and operating performance are issuer disclosures; category-level share data, consumer repeat-purchase rates and independent brand comparisons are absent.","Price/mix/other combines pricing, promotions, mix and other factors, preventing isolation of pure realized price changes or elasticity.","Glad license scope, remaining protection period and incremental earnings contribution are not quantified. No comparative cost advantage, network effect, switching-cost moat or efficient-scale barrier is established.","The proxy supplies actual compensation and governance evidence, but the ownership excerpts are incomplete. Executive ownership compliance and comprehensive board effectiveness cannot be established.","ERP efficiencies and acquisition synergies are expectations rather than demonstrated durable competitive advantages. The November 2026 shareholder meeting had not occurred at the latest supplied filing date."],"qualityAssessments":[{"category":"moat","checks":[{"criterion":"structural_advantage","grade":2,"rationale":"Exclusive retained Glad licenses provide a concrete contractual advantage, while brands and reported market-share gains support differentiation. Portfolio-wide barriers and the licenses’ economic contribution are not established.","evidenceIds":["e1","e2","e3","e4","e5"]},{"criterion":"durability","grade":2,"rationale":"Glad retains its licenses after venture termination, supporting continuity. Brand positions require sustained advertising and innovation, and no protection horizon or long record of share gains is supplied.","evidenceIds":["e2","e6","e1"]},{"criterion":"customer_dependency","grade":1,"rationale":"Private-label alternatives, price-based competition and short customer performance obligations indicate fragile dependency. Brand preference is evidenced indirectly, but material switching friction is not.","evidenceIds":["e3","e5","e17","e1"]},{"criterion":"erosion_resilience","grade":1,"rationale":"Fiscal 2025 share gains are favorable, but fiscal 2026 competitive pressure, missed expectations and margin contraction show limited recent resilience. Shipment timing prevents interpreting the full volume decline as competitive erosion.","evidenceIds":["e1","e7","e8","e10","e15","e16"]}]},{"category":"pricing_power","checks":[{"criterion":"realized_pricing","grade":2,"rationale":"Pricing actions supported fiscal 2024 margin recovery. Fiscal 2025 brought higher promotional spending, and fiscal 2026 price/mix/other was flat overall and negative in Household and Lifestyle. Outcomes are mixed; the bridge does not isolate pure pricing.","evidenceIds":["e12","e13","e9","e14"]},{"criterion":"retention","grade":2,"rationale":"Assessed indirectly from reported market-share gains and continuing sales. These support continuing consumer demand, while competitive pressure weakens confidence. ERP-related inventory movements obscure fiscal 2026 demand trends; no repeat-purchase rate is supplied.","evidenceIds":["e1","e7","e15"]},{"criterion":"margin_resilience","grade":1,"rationale":"Earlier pricing and cost-saving benefits did not prevent a 290-basis-point gross-margin decline in fiscal 2026 as manufacturing, logistics and lower sales outweighed savings. This is realized weakness, without establishing that pricing alone caused it.","evidenceIds":["e12","e10","e16"]},{"criterion":"contractual_freedom","grade":2,"rationale":"Implemented pricing actions and customer performance obligations of one year or less support some ability to reset commercial terms. Trade promotions and concentrated retail sales constrain practical freedom; unilateral repricing rights are not disclosed.","evidenceIds":["e12","e17","e18","e11"]}]},{"category":"strong_management","checks":[{"criterion":"capital_discipline","grade":2,"rationale":"Transformation spending of approximately $580 million matched the upper end of the prior range, and adjusted free cash flow of $881 million exceeded $856 million of dividends and repurchases. However, adjusted cash flow adds back the $476 million venture payment; unadjusted operating cash flow less capital expenditure was $405 million. Increased acquisition-related indebtedness and an actual downgrade temper the assessment, while acquisition returns remain unproven.","evidenceIds":["e23","e25","e19","e20","e21","e22","e36"]},{"criterion":"incentive_alignment","grade":3,"rationale":"Actual fiscal 2026 incentives reflected underperformance: the short-term company multiplier was 54%, and the completed performance-share cycle was certified at 69% of target. Net-share retention requirements reinforce alignment. These are actual outcomes and existing requirements, although complete ownership compliance and incentive-adjustment details are unavailable.","evidenceIds":["e26","e27","e28","e7","e8"]},{"criterion":"execution","grade":2,"rationale":"Completed ERP implementation and spending within the prior range demonstrate delivery, alongside fiscal 2025 share gains. Operational transition challenges and acknowledged misses in fiscal 2026 offset those achievements. Execution is assessed from operating outcomes; prospective efficiencies are not counted as realized success.","evidenceIds":["e24","e23","e25","e1","e7","e8","e35"]},{"criterion":"governance","grade":2,"rationale":"A lead independent director, independent committee chairs and an independent CEO search committee provide disclosed oversight mechanisms. The auditor found effective financial-reporting controls, subject to the GOJO exclusion. Combined chair and CEO roles and limited evidence of oversight effectiveness prevent a stronger assessment.","evidenceIds":["e29","e30","e31","e32","e33","e34"]}]}],"financialAssessments":[],"qualityPolicy":"quality-scores-3","sourcePolicy":"issuer-evidence-5","basisHash":"94c5956bab8ccf93927eadbf9bb3739cc54cc14f8407b1448a3878b2dfd25f7c","updatedAt":"2026-10-19T10:18:25.029Z","sources":[{"id":"filing-1","url":"https://www.sec.gov/Archives/edgar/data/21076/000002107626000034/clx-20260630_d2.htm","publishedAt":"2026-08-07","sha256":"5c4479f08eeb304ca314392a4639c5608f8906827c0d338249c7f61bde845cc3","citationPolicy":"numeric-lines-1","dateKind":"filed"},{"id":"filing-2","url":"https://www.sec.gov/Archives/edgar/data/21076/000002107625000039/clx-20250630.htm","publishedAt":"2025-08-08","sha256":"fb678fdf2e096885f09238a39bea18d1b20c0e49b13aca9cc37093e9e6c00e13","citationPolicy":"numeric-lines-1","dateKind":"filed"},{"id":"filing-3","url":"https://www.sec.gov/Archives/edgar/data/21076/000002107624000030/clx-20240630.htm","publishedAt":"2024-08-08","sha256":"dd13cf1e3822e32eb562f9347a55a569048decaf5e8c4e2947e1312ca157d0ad","citationPolicy":"numeric-lines-1","dateKind":"filed"},{"id":"filing-4","url":"https://www.sec.gov/Archives/edgar/data/21076/000002107626000019/clx-20260331.htm","publishedAt":"2026-04-30","sha256":"9beb378f4cc4cf43c05fcbff3f546b08e4c0683534165cc53524e55e12373f65","citationPolicy":"numeric-lines-1","dateKind":"filed"},{"id":"filing-5","url":"https://www.sec.gov/Archives/edgar/data/21076/000002107626000010/clx-20251231.htm","publishedAt":"2026-02-03","sha256":"dc03b4df30309770d8a2c838656ec4e74b77a7acc660a0a2b3fbf6e45c40d2c9","citationPolicy":"numeric-lines-1","dateKind":"filed"},{"id":"filing-6","url":"https://www.sec.gov/Archives/edgar/data/21076/000155278126000516/e26316_clx-def14a.htm","publishedAt":"2026-10-07","sha256":"14d92371e3676b3c3c8ccc75a81ba7db63c6102cba452d95490e75eb53d6e99f","citationPolicy":"numeric-lines-1","dateKind":"filed"}],"model":"gpt-6.1-sol","providerId":"codex:0569735c0043aae4e1f083960c1821b4b796aaec5f42305c455508779193ff78","usage":{"input_tokens":87533,"cached_input_tokens":0,"cache_write_input_tokens":0,"output_tokens":3870,"reasoning_output_tokens":141}},"signals":[{"period":"2022","end":"2022-06-30","values":{"gross_margin":35.809765020402416,"operating_margin":null,"roic":null,"fcf_margin":7.527789503306599,"sbc_revenue":0.7316729984522302},"issues":{"peg":"TTM earnings per diluted share growth is zero or negative; a growth-adjusted multiple requires positive growth.","pfcf_growth":"TTM FCF per diluted share growth is zero or negative; a growth-adjusted multiple requires positive growth.","ev_ebitda":"Operating income is unavailable in the extracted statements for this period.","software_capex":"Separately disclosed software and intangible investment is unavailable in the extracted statements for this period.","operating_margin":"Operating income is unavailable in the extracted statements for this period.","ebitda_margin":"Operating income is unavailable in the extracted statements for this period.","roic":"Operating income is unavailable in the extracted statements for this period.","roce":"Operating income is unavailable in the extracted statements for this period.","roiic":"Operating income is unavailable in the extracted statements for this period.","roic_wacc":"Enter a WACC assumption from 0 to 100%.","net_debt_ebitda":"Operating income is unavailable in the extracted statements for this period.","interest_coverage":"Operating income is unavailable in the extracted statements for this period."}},{"period":"2023","end":"2023-06-30","values":{"gross_margin":39.35579916091487,"operating_margin":null,"roic":null,"fcf_margin":12.586276898091759,"sbc_revenue":0.987955068344837},"issues":{"peg":"TTM earnings per diluted share growth is zero or negative; a growth-adjusted multiple requires positive growth.","ev_ebitda":"Operating income is unavailable in the extracted statements for this period.","software_capex":"Separately disclosed software and intangible investment is unavailable in the extracted statements for this period.","operating_margin":"Operating income is unavailable in the extracted statements for this period.","ebitda_margin":"Operating income is unavailable in the extracted statements for this period.","roic":"Operating income is unavailable in the extracted statements for this period.","roce":"Operating income is unavailable in the extracted statements for this period.","roiic":"Invested capital did not increase versus the prior year. ROIIC requires a positive increase.","roic_wacc":"Enter a WACC assumption from 0 to 100%.","net_debt_ebitda":"Operating income is unavailable in the extracted statements for this period.","interest_coverage":"Operating income is unavailable in the extracted statements for this period."}},{"period":"2024","end":"2024-06-30","values":{"gross_margin":42.97194417030876,"operating_margin":null,"roic":null,"fcf_margin":6.809530523050896,"sbc_revenue":1.0432821091216693},"issues":{"pfcf_growth":"TTM FCF per diluted share growth is zero or negative; a growth-adjusted multiple requires positive growth.","ev_ebitda":"Operating income is unavailable in the extracted statements for this period.","software_capex":"Separately disclosed software and intangible investment is unavailable in the extracted statements for this period.","operating_margin":"Operating income is unavailable in the extracted statements for this period.","ebitda_margin":"Operating income is unavailable in the extracted statements for this period.","roic":"Operating income is unavailable in the extracted statements for this period.","roce":"Operating income is unavailable in the extracted statements for this period.","roiic":"Operating income is unavailable in the extracted statements for this period.","roic_wacc":"Enter a WACC assumption from 0 to 100%.","net_debt_ebitda":"Operating income is unavailable in the extracted statements for this period.","interest_coverage":"Operating income is unavailable in the extracted statements for this period."}},{"period":"2025","end":"2025-06-30","values":{"gross_margin":45.22804054054054,"operating_margin":null,"roic":null,"fcf_margin":10.712274774774775,"sbc_revenue":1.1402027027027026},"issues":{"ev_ebitda":"Operating income is unavailable in the extracted statements for this period.","software_capex":"Separately disclosed software and intangible investment is unavailable in the extracted statements for this period.","operating_margin":"Operating income is unavailable in the extracted statements for this period.","ebitda_margin":"Operating income is unavailable in the extracted statements for this period.","roic":"Operating income is unavailable in the extracted statements for this period.","roce":"Operating income is unavailable in the extracted statements for this period.","roiic":"Operating income is unavailable in the extracted statements for this period.","roic_wacc":"Enter a WACC assumption from 0 to 100%.","net_debt_ebitda":"Operating income is unavailable in the extracted statements for this period.","interest_coverage":"Operating income is unavailable in the extracted statements for this period."}},{"period":"2026","end":"2026-06-30","values":{"gross_margin":42.32142857142857,"operating_margin":null,"roic":null,"fcf_margin":6.026785714285714,"sbc_revenue":0.7142857142857143},"issues":{"peg":"TTM earnings per diluted share growth is zero or negative; a growth-adjusted multiple requires positive growth.","pfcf_growth":"TTM FCF per diluted share growth is zero or negative; a growth-adjusted multiple requires positive growth.","ev_ebitda":"Operating income is unavailable in the extracted statements for this period.","software_capex":"Separately disclosed software and intangible investment is unavailable in the extracted statements for this period.","operating_margin":"Operating income is unavailable in the extracted statements for this period.","ebitda_margin":"Operating income is unavailable in the extracted statements for this period.","roic":"Operating income is unavailable in the extracted statements for this period.","roce":"Operating income is unavailable in the extracted statements for this period.","roiic":"Operating income is unavailable in the extracted statements for this period.","roic_wacc":"Enter a WACC assumption from 0 to 100%.","net_debt_ebitda":"Operating income is unavailable in the extracted statements for this period.","interest_coverage":"Operating income is unavailable in the extracted statements for this period."}}],"sources":[{"id":"filing-1","url":"https://www.sec.gov/Archives/edgar/data/21076/000002107626000034/clx-20260630_d2.htm","publishedAt":"2026-08-07","sha256":"5c4479f08eeb304ca314392a4639c5608f8906827c0d338249c7f61bde845cc3","citationPolicy":"numeric-lines-1","dateKind":"filed"},{"id":"filing-2","url":"https://www.sec.gov/Archives/edgar/data/21076/000002107625000039/clx-20250630.htm","publishedAt":"2025-08-08","sha256":"fb678fdf2e096885f09238a39bea18d1b20c0e49b13aca9cc37093e9e6c00e13","citationPolicy":"numeric-lines-1","dateKind":"filed"},{"id":"filing-3","url":"https://www.sec.gov/Archives/edgar/data/21076/000002107624000030/clx-20240630.htm","publishedAt":"2024-08-08","sha256":"dd13cf1e3822e32eb562f9347a55a569048decaf5e8c4e2947e1312ca157d0ad","citationPolicy":"numeric-lines-1","dateKind":"filed"},{"id":"filing-4","url":"https://www.sec.gov/Archives/edgar/data/21076/000002107626000019/clx-20260331.htm","publishedAt":"2026-04-30","sha256":"9beb378f4cc4cf43c05fcbff3f546b08e4c0683534165cc53524e55e12373f65","citationPolicy":"numeric-lines-1","dateKind":"filed"},{"id":"filing-5","url":"https://www.sec.gov/Archives/edgar/data/21076/000002107626000010/clx-20251231.htm","publishedAt":"2026-02-03","sha256":"dc03b4df30309770d8a2c838656ec4e74b77a7acc660a0a2b3fbf6e45c40d2c9","citationPolicy":"numeric-lines-1","dateKind":"filed"},{"id":"filing-6","url":"https://www.sec.gov/Archives/edgar/data/21076/000155278126000516/e26316_clx-def14a.htm","publishedAt":"2026-10-07","sha256":"14d92371e3676b3c3c8ccc75a81ba7db63c6102cba452d95490e75eb53d6e99f","citationPolicy":"numeric-lines-1","dateKind":"filed"}],"history":[{"version":10,"updatedAt":"2026-10-29T11:13:49.129Z","verdict":"narrow","value":null},{"version":9,"updatedAt":"2026-10-28T04:32:09.967Z","verdict":"narrow","value":null},{"version":8,"updatedAt":"2026-10-24T08:25:07.531Z","verdict":"narrow","value":null},{"version":7,"updatedAt":"2026-10-23T23:21:09.227Z","verdict":"narrow","value":null},{"version":6,"updatedAt":"2026-10-22T23:15:14.849Z","verdict":"narrow","value":null},{"version":5,"updatedAt":"2026-10-19T13:57:15.039Z","verdict":"narrow","value":null},{"version":4,"updatedAt":"2026-10-19T13:54:22.947Z","verdict":"narrow","value":null},{"version":3,"updatedAt":"2026-10-18T16:35:43.872Z","verdict":"narrow","value":null},{"version":2,"updatedAt":"2026-10-18T02:27:49.793Z","verdict":"narrow","value":null},{"version":1,"updatedAt":"2026-10-18T02:18:02.026Z","verdict":null,"value":null}],"hasRequested":false,"requestStatus":"completed","researchIssue":null,"archivedMoat":null,"scope":"supported_catalog"}